DECADE-pilot. Study to reduce the 10-year risk for cardiovascular diseases in primary care

DECADE-pilot. Study to reduce the 10-year risk for cardiovascular diseases in primary care - DECADE-pilot

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010584

Enrollment

Registered

2016-07-07

Start date

2016-07-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I10 I11 I12 I13 I15 I20 I25 I34 I35 I36 I37 I42 I44 I45 I48 I50 I63 I65 I66 G45 I70 I73.9 E10 E11 E12 E13 E14 R73.0 R73.9 E66 E78

Interventions

Group 1: Control group: medical advice based on the cardiovascular risk calculator “arriba” that is commonly used in GP practices. Upon completion of the study, patients of the control group will als

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) At least one risk factor for a cardiovascular disease or an existing cardiovascular disease, (2) Willingness to take part in two written surveys, (3) Signing the informed consent.

Exclusion criteria

Exclusion criteria: (1) Addiction to alcohol or drugs, severe eating disorder, (2) Considerable cognitive impairment or mental disease, (3) Severe consuming disease or short life expectancy, (4) Pregnancy, (5) Actual or planned participation in a rehabilitative measure.

Design outcomes

Primary

Measure	Time frame
Change of patient activation (PAM-13-D) from the beginning of the study (inclusion of patient = T0) to the end of the intervention (T1).	—

Secondary

Measure	Time frame
EndpunktChange of self-evaluation of health (EQ-VAS) and health behaviour (IRES) from T0 to T1. Patients of both intervention and control group evaluate at T1 the usefulness of patient material they received (USE). Furthermore patients self-evaluate their goal attainment (adapted GAS) and their satisfaction with goal attainment (own development). The patients evaluate as well the consultation and support by their GP (own development). Additionally we analyse the following mean changes of clinical outcomes between T0 and T1 : systolic blood pressure, total cholesterol, HDL cholesterol, HbA1c, cardiovascular risk score, and body mass index.	—

Measure

Time frame

EndpunktChange of self-evaluation of health (EQ-VAS) and health behaviour (IRES) from T0 to T1. Patients of both intervention and control group evaluate at T1 the usefulness of patient material they received (USE). Furthermore patients self-evaluate their goal attainment (adapted GAS) and their satisfaction with goal attainment (own development). The patients evaluate as well the consultation and support by their GP (own development). Additionally we analyse the following mean changes of clinical outcomes between T0 and T1 : systolic blood pressure, total cholesterol, HDL cholesterol, HbA1c, cardiovascular risk score, and body mass index.

—

Countries

Germany

Contacts

Public ContactIris Tinsel

Lehrbereich Allgemeinmedizin, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwig-Universität Freiburg, Deutschland

iris.tinsel@uniklinik-freiburg.de+49 761 270 77920

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 9, 2026